RAPAMUNE
Google image searchProduct monograph
Active ingredient
sirolimus, 1 MG/ML
DIN: 02243237
Dosage form(s): SOLUTION
Route(s) of administration: ORAL
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 10-JUN-2013
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AH — Mammalian target of rapamycin (mTOR) kinase inhibitors (ATC, ATC/DDD)
- L04AH01 — SIROLIMUS (ATC/DDD)
Reference brand drug: Rapamune
Pharmaceutical standard: MFR
